Series A to Series D: Enticing Investors and Nailing Your Investor Pitch at Different Stages of Fundraising
By Kenton Chow
One of the greatest benefits of years of experience is the perspective you gain having many fundraising data points and the perspective of been there, done that. I believe that one of FLG’s most important value-added services to our clients is our partners’ impressive domain sector expertise and depth of…Read More
Read MoreConsumer CFOs: Strategic Change Agents Needed NOW
By Stephanie Roberts
CFOs at consumer companies should play critical roles, anticipating major trends and recommending the pivots necessary to remain competitive. The CFO is always in a unique position to influence CEOs on pivots necessary to position a company for success amidst rapidly changing landscapes. But this couldn’t be more evident than it…Read More
Read MoreLife Sciences Companies: Sell Now or Sell Later?
By Mark Murray
Life sciences companies in their early stages are in constant need of capital to continue along their path to meeting clinical milestones. Most are pre-revenue and focused on successful completion of Phase I and II clinical trials. And with strong clinical data, these investment prospects are attractive to sources of…Read More
Read MoreThe 5 Essential Attributes of an “A-List” Chief Financial Officer
By Jeff Kuhn
When a company hires a Chief Financial Officer (CFO), the Board and management team have a unique opportunity to bring on a trusted partner and colleague for their CEO, and an experienced financial executive to strategically help chart a positive course for the enterprise. Many CEOs and Boards typically look…Read More
Read More